Cytox raises GBP2.6m in funding round led ed by Catapult Ventures
Cytox, a specialist in genetic testing for Alzheimer’s Disease, has raised GBP2.6m to fund the commercial launch and international roll out of its novel service. The funding round was led by the GM&C Life Sciences Fund, managed by Catapult Ventures, alongside existing and new investors, including Perivoli Innovations, The Rainbow